Lithium Carbonate Tablet, Film Coated, Extended Release
Product Images NDC 23155-763

3 FDA label images from Heritage Pharmaceuticals Inc. D/b/a Avet Pharmaceuticals Inc. · Packaging, Regulatory Labels, and Product Appearance

Product Visual Gallery

This gallery contains 3 technical images submitted to the FDA as part of the official labeling for Lithium Carbonate (NDC 23155-763). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Heritage Pharmaceuticals Inc. D/b/a Avet Pharmaceuticals Inc., these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

Distributor Logo (84eb428b 05c9 4585 83ba 85e800b5b424 01)

FDA Label Image

300 100 (300 100)

300 100 (300 100)
Label for Lithium Carbonate Extended-Release Tablets USP, 300 mg, film-coated tablets, packaged in a bottle of 100 tablets. The label shows the product name, strength, quantity, Rx only designation, and is distributed by Avet Pharmaceuticals Inc. It includes storage instructions and a barcode.*
FDA Label Image

300 500 (300 500)

300 500 (300 500)
Label for Lithium Carbonate Extended-Release Tablets, USP 300 mg by Avet Pharmaceuticals Inc. The label indicates 500 tablets, film-coated, oral use, prescription only. It includes storage instructions, child safety warnings, and a barcode, with a revision date of 08/2025 and NDC 23155-763-05.*

* About these descriptions: Image descriptions on this page are generated by automated AI analysis of the product label images from the manufacturer's FDA label submission (SPL). They are provided for reference only and may contain errors or omissions. Always rely on the printed label itself and the official FDA labeling, and consult a pharmacist or healthcare professional with any questions about this product.